Skip to main content
. 2020 Sep 12;21(18):6684. doi: 10.3390/ijms21186684

Table 5.

BER/MMR-related proteins targeted in cancer therapy.

BER/MMR
Protein Drug Name Combined Treatment Possible Synthetic Lethal Interaction References
APE1 E3330 Bleomycin PARP1 inhibition [163,164,165,166,167,168]
POL-β NSC666715 Alkylating agents MSH2/MLH1 inhibition [169,170]

For each target it is reported: name of the drugs currently in analysis; combination of target inhibition and classic anti-cancer therapy under study; possible synthetic lethality interaction; references.